2018 Pan Pacific Lymphoma Conference

 

2018 Pan Pacific Lymphoma Conference
J

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
By 2018 Pan Pacific Lymphoma Conference FEATURING Julie M. Vose
420 views
August 21, 2018
Comments 1
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Novel Therapies in Lymphoma
13:17

Novel Cell Pathway Targeted Agents for DLBCL: Determining Cell-of-Or…

2018 Pan Pacific Lymphoma Conference

J. Vose

129 views
25:30

How do we Incoporate PET-CT into Standard of Lymphoma Care and Resea…

2018 Pan Pacific Lymphoma Conference

B. Cheson

45 views
09:28

Novel Cell Pathway Targeted Agents for Relapsed DLBCL

2018 Pan Pacific Lymphoma Conference

J. Vose

420 views
22:02

New Antibody-Drug Conjugates

2018 Pan Pacific Lymphoma Conference

B. Kahl

527 views
17:33

Novel-Novel Drug Combinations in B-cell Malignancies

2018 Pan Pacific Lymphoma Conference

K. Dunleavy

255 views